Novel technology enables detection of early-stage lung cancer when surgical cure still is possible. New platform tests blood or saliva of early-stage lung cancer patients to identify two cancer-linked mutations, reports The Journal of Molecular Diagnostics.

See the source article by following the link below:
Novel technology enables detection of early-stage lung cancer when surgical cure still is possible. New platform tests blood or saliva of early-stage lung cancer patients to identify two cancer-linked mutations, reports The Journal of Molecular Diagnostics.